Research Activity
Utility of itraconazole and terbinafine in mucormycosis: a proof-of-concept analysis
Start at : January 26, 2022
Published In BMJ Journal
Mucormycosis is a disease caused by a group of molds called mucoromycetes and has high mortality rate. The second wave of COVID-19 in India lasted from March to June 2021, leaving a huge burden on the healthcare system and intensive care units (ICUs).